Clinical Trial Update: An Investigation of Levetiracetam in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating levetiracetam in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: University of Oxford | Conditions: Alzheimer Disease, Epilepsy | Phase 2 | Status: COMPLETED